Candida glabrata prosthetic hip infection

Am J Orthop (Belle Mead NJ). 2012 Nov;41(11):500-5.

Abstract

We present a case of a 60-year-old Caucasian woman carrying a 2-year-old hip prosthesis infected by Candida glabrata dose-dependent susceptible to fluconazole and voriconazole. Resection arthroplasty was performed. Six weeks of caspofungin plus liposomal amphotericin combination therapy achieved joint sterilization and allowed a successfully reimplantation arthroplasty. In addition we review 9 cases of C. glabrata prosthetic joint infection described to date in the literature.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Candida glabrata / isolation & purification*
  • Candidiasis / etiology*
  • Candidiasis / microbiology
  • Candidiasis / therapy
  • Device Removal
  • Female
  • Hip Prosthesis / microbiology
  • Humans
  • Middle Aged
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / microbiology*
  • Prosthesis-Related Infections / therapy
  • Reoperation

Substances

  • Antifungal Agents